I ended my last piece with a sentence I haven't stopped thinking about: Your skin did not fail you. It changed.
This is the argument underneath it.
We have built an enormous skincare and aesthetics industry around identifying what has changed on the surface and deciding how to correct it. Pigment appears, so we treat the pigment. Breakouts begin, so we treat the acne. Texture changes, so we resurface it. Skin becomes lax, so we tighten it. It gets dry, so we moisturize it. Lines become more visible, so we increase turnover.
There is nothing inherently wrong with any of those interventions. There are brilliant dermatologists, physicians, cosmetic chemists and aesthetic practitioners doing genuinely transformative work, and this is not an argument against correction.
Medicine is appropriately organized around identifying pathology and treating disease. It should be. The problem begins when beauty borrows that framework and applies it to every visible consequence of being alive.
Pigmentation, dryness, laxity, breakouts, texture and sensitivity may appear separately on the face, but biologically, they don't necessarily arrive separately. Skin's water balance, lipid composition, inflammatory environment, collagen architecture, pigment behavior, recovery capacity and tolerance are all functioning inside the same living system.
When you view the face as a collection of outputs, more intervention feels perfectly logical. When the pigment persists, increase the pigment treatment. When texture isn't moving fast enough, exfoliate more. When lines become more visible, increase the retinoid. Then, when the skin starts objecting to everything we have layered onto it, sensitivity itself becomes another problem requiring another product.
The more interesting question is what happened before all of those outputs appeared.
And nowhere is that more obvious than during periods when the body itself is changing.
Three Different Transitions. Three Different Biological Stories.
Postpartum, perimenopause and menopause, and significant weight loss associated with GLP-1-based therapies are not three versions of the same skincare problem. They involve different hormones, different tissues, different timelines and completely different physiological demands.
What they have in common is what happens next. A woman sees something new in the mirror, the beauty industry identifies the visible defect, and almost nobody stops long enough to ask what changed upstream.
Postpartum: The Body Did Not Hit "Restore Previous Settings"
Pregnancy ends dramatically. Postpartum biology does not.
Estrogen and progesterone fall rapidly after delivery. If a woman is breastfeeding, lactation creates another distinct hormonal environment. Sleep may become fragmented, stress changes, nutrition and routines can become unpredictable, and the body is simultaneously recovering from pregnancy and birth while adapting to an entirely new physiological workload.
Skin is living inside all of that.
Yet culturally, postpartum women are handed a remarkably simple instruction: get back. Get your body back, your energy back, your hair back, your skin back, yourself back. We talk about pregnancy as though it were a temporary software update and somewhere, hidden in Settings, there is a button marked UNDO.
The actual skin research is far more nuanced, which is exactly why I find it interesting. Studies following women through pregnancy and postpartum have documented changes in measures such as transepidermal water loss and skin roughness, but not every measure changes, not every woman experiences the same thing, and the researchers themselves have been appropriately cautious about turning those findings into universal conclusions.
That matters because postpartum should not become another beauty diagnosis.
Some women become much drier. Some break out. Some become more reactive. Some continue dealing with pigment that appeared during pregnancy. Some somehow become dry and acne-prone at the same time. Others notice relatively little change.
Postpartum is not one skin state. It is a biological transition with an enormous range of visible outputs.
That completely changes how I think we should approach the woman standing in front of the mirror wondering what happened.
If she develops dryness, pigment and breakouts after giving birth, did she suddenly acquire three unrelated skincare failures? Or did something fundamental change in the biological environment producing those outputs?
She is still allowed to want the pigment gone. She can absolutely want the breakout controlled. She can want her luminosity back yesterday. Understanding the transition isn't an instruction to lower her expectations or tell her to be grateful for whatever her skin is doing because she just had a baby.
It simply means we stop pretending that forcing skin toward its previous baseline is the same thing as understanding what it needs now.
The question becomes less about how quickly we can push it back and more about what conditions we are asking it to perform in while we do.
Perimenopause and Menopause: When the Old Instructions Meet New Biology
Perimenopause is where this entire model stopped making sense to me personally.
I had skin I understood, until I didn't. Products I had used successfully for years suddenly felt different. My skin became drier, more reactive, less resilient and less predictable, and I kept coming back to a question I hear from women constantly:
I've used this for ten years. Why can I suddenly not tolerate it?
Because history of tolerance is not the same thing as present readiness.
The formulation may not have changed. The tissue receiving it did.
This is not simply a cultural reclassification of a woman as "mature." Menopause is associated with measurable changes in skin structure, including collagen, thickness and elasticity. Research has also identified changes in stratum-corneum lipids after menopause, including ceramide differences that are directly relevant to the architecture of the outer barrier.
The important thing isn't to turn every woman into a diagram of estrogen decline. Individual experiences vary enormously, and we are still learning a great deal about the skin specifically during the perimenopausal transition.
What matters is recognizing that a woman may not simply be accumulating wrinkles one at a time. The tissue itself can be changing. Collagen architecture can change. Surface lipids can change. Water balance can change. Elastic behavior can change. Recovery may feel different. Tolerance may feel different. Several of those things can be happening at once, yet we continue to treat the visible outputs as unrelated problems.
Then comes the part I find almost absurd.
At precisely the point when some women may have less margin for unnecessary disruption, we market more disruption to them because they are aging. More exfoliation, more resurfacing, more concentrated activity, more turnover, more procedures and more urgency.
We take a changing biological system and conclude that the obvious solution is to apply more pressure to it.
That is the paradox.
And I want to be very clear here, because this is where "barrier-first" skincare can get terribly boring, terribly fast. I am not arguing for less ambitious skincare.
I want the firmness. I want smoother texture. I want luminosity and bounce. I want pigmentation addressed. I want skin to look spectacular at fifty, sixty, seventy and beyond.
Correction without context is bad engineering.
If the system changed, increasing the amount of pressure we apply to it without reconsidering the system is an astonishingly primitive response.
GLP-1 Use and Significant Weight Loss: When Better Health Changes the Face
Then we gave the world "Ozempic face," which may be one of the laziest explanations we have come up with for an incredibly interesting modern phenomenon.
The visible changes people are describing are real. The problem is that the nickname skips directly from observation to mechanism without doing any of the work in between.
GLP-1-based therapies and related incretin medications can produce substantial weight loss. When a body loses a meaningful amount of mass, the tissues that give the face its volume and support are not protected from that change simply because we would prefer them to be.
Emerging imaging research in people using GLP-1 agonists has begun to quantify reductions in midfacial volume, particularly in superficial facial compartments, with greater weight loss associated with greater volume change. That research is still early and small. What it does not prove is equally important: it does not establish that these medications directly destroy facial collagen, chemically "age" the skin or create some unique drug-induced facial disorder.
The medication may be the instrument through which the weight was lost. The visible facial change is more convincingly connected, at this point, to the magnitude and distribution of tissue loss than to a proven toxic effect of the medication on skin.
That distinction matters.
A woman may have made one of the most meaningful improvements to her metabolic health in years. She may feel better, move better, see better laboratory markers and feel more at home in her body, while simultaneously looking in the mirror and thinking, I don't like what happened to my face.
Those ideas do not cancel each other out.
A successful health intervention can still produce a visible change someone wants to address. Those two truths are allowed to coexist.
She doesn't have to pretend she loves facial volume loss in order to be grateful for better health, and she doesn't need to be told that her medication "ruined" her face.
Her body changed. The architecture underneath the skin changed with it.
Now we have a more intelligent starting point for deciding what skincare can reasonably improve, what may benefit from a procedure, and what no topical product should dishonestly promise to replace.
That is what context does. It doesn't make us less corrective. It makes the correction more precise.
Skin Isn't Failing. It's Reporting.
These three women do not have the same biology, and they should not have the same treatment plan. They may not even share a single visible symptom.
What they share is the mistake we make when we look only at the output.
Skin is extraordinarily responsive to what is happening around it and underneath it. Hormones, weight change, medication, sleep, stress, environment, treatment and time all alter the context in which skin is being asked to function.
What appears on the surface is information about that system.
Skin isn't failing. It's reporting.
That is where Hydrate, Calm, Strengthen and Signal become more useful to me than another permanent skin label. Not as four product categories and not as four mandatory boxes that must be checked every night, but as four ways to interrogate the system.
What appears depleted? What is under unnecessary pressure? What needs structural support? And only then, what do we actively want to change?
The answer can be completely different for a woman six weeks postpartum than it is for a woman two years into menopause. It can change again for a woman who has just lost sixty pounds. It can even change for the same woman during different seasons of the same year.
The framework remains useful precisely because the prescription is allowed to move.
And this is where I think skincare gets far more interesting than dividing ingredients into "gentle" and "strong."
Go Look at Your Bathroom Shelf
You do not have to own a single Alchemy product to test this idea.
Go look at what you're using now and forget the brand names for a moment. Forget how much each bottle cost, whether the ingredient list looks impressive, or how many clinical-sounding words are printed across the front.
Look instead at the work each product is doing.
How much of your routine exists primarily to correct?
Maybe there is a retinoid, vitamin C, an exfoliating acid, a pigment treatment and a peptide serum. Maybe another acid is hiding in your toner. Maybe your cleanser promises "renewal." Maybe you have a weekly peel or regular procedure sitting on top of all of it.
Now look at how much of that routine was deliberately designed to support the conditions surrounding all of that activity.
I don't mean the emergency moisturizer you bought because your face started peeling, or the calming serum that appeared only after the rest of your routine became intolerable. I mean deliberate support built into the architecture from the beginning.
None of those products has to be bad for the system to be poorly designed.
Maybe your retinoid is excellent. Keep it. Maybe your vitamin C gives you results you love. Keep it. Maybe your dermatologist prescribed something medically appropriate that works beautifully for you. This is not an invitation to disregard medical treatment.
What may need reconsideration isn't the product itself. It may be the system around it.
The frequency. The sequence. The redundancy. The recovery burden. The cleanser it follows. Whether exfoliation is genuinely improving the surface or simply happening because Tuesday arrived and your calendar says acid night. Whether three different products are performing essentially the same high-activity job while another important function is barely represented.
Clinical dermatology gives us a useful proof of concept here. In research involving patients using active acne treatment, adding barrier-supportive cleansing and moisturizing reduced dryness, redness and scaling while improving measures of barrier recovery. The corrective treatment didn't have to become less serious for the surrounding support to become more intelligent.
That is the conversation I want skincare to start having.
Instead of asking how much skin can survive, ask what an intervention costs the system, what it gives us in return, and how intelligently we can support the system around it.
Every product should have to justify that equation.
"Gentle" Versus "Effective" Was Always the Wrong Debate
This false choice drives me crazy.
On one side, we have aggressive skincare: maximum percentages, maximum turnover, maximum activity, with an implication hanging in the air that discomfort is evidence we are doing something important.
On the other side, "sensitive skin" is too often treated like a padded room full of oatmeal and glycerin where nobody is allowed to pursue meaningful transformation.
Apparently those are the options.
I reject both.
There is nothing inherently sophisticated about repeatedly irritating skin, and there is nothing ambitious about assuming changing or reactive skin should spend the rest of its life in bland maintenance.
Those ideas are not in conflict.
If an intervention produces a meaningful result with minimal recovery burden, that's performance. If a product creates enough disruption that three other products have to be recruited simply to make continued use tolerable, that cost belongs in the evaluation too. And if correction can be sequenced, paced or supported in a way that improves the overall result, that isn't less serious skincare.
It's better designed skincare.
I don't want women choosing between spectacular results and comfortable skin. I want us questioning why we accepted that tradeoff in the first place.
The Defense Is the Architecture
This is the deeper reason Alchemy was built as a system rather than a collection of hero ingredients.
Not because every woman needs eight products. She doesn't. Not because skincare should be complicated. It shouldn't. And certainly not because there is one sacred routine everyone should follow forever.
Alchemy was engineered around the assumption that the conditions will move.
Sometimes the job is recovery. Sometimes it is maintenance. Sometimes the skin is in a beautiful place and we can lean harder into correction. Sometimes life happens, biology changes, tolerance shifts and the intelligent move is to pull back without dismantling the entire system.
The foundation can remain while the intensity changes.
Cleansing should not create a debt the rest of the routine has to repay. Hydration should do more than make the skin temporarily feel wet. Barrier support should not exist only as an apology after an active has gone too far. Surface refinement should improve the surface without turning recovery into a hobby. Advanced signaling should have a clear reason for being there rather than existing simply because another impressive ingredient became available.
And yes, this is probably exactly the kind of skincare system you get when you hand a systems engineer with a technology background a 50th birthday and a beaker.
I did not approach formulation by asking how many trendy actives I could fit into a bottle. I approached it like a system: What is the objective? What conditions affect performance? Where is the unnecessary friction? What does each component contribute? What is the cost of that contribution? And what happens to the entire system when one variable changes?
That is also why I think products should have to earn their place on multiple timelines.
A formula should contribute something worthwhile now. It should begin changing the experience or appearance of the skin soon. And if we are asking someone to use it consistently for months, there should be an intelligent reason to believe continued use can move the baseline later.
I don't want instant gratification with no trajectory, but I also don't want delayed gratification used as an excuse for a miserable product experience. Women should not have to spend twelve uncomfortable weeks hoping irritation eventually turns into proof that their skincare is working.
The order matters. The cadence matters. The recovery cost matters.
And the result absolutely matters.
That is performance engineering too.
And Yes, I Still Want Spectacular Results
There is a version of this conversation that inevitably ends with someone suggesting that perhaps women simply need to accept aging, postpartum change or whatever else their bodies have done.
That is not what I am saying.
The postpartum woman is allowed to want her pigment gone. The woman in menopause is allowed to want firmer skin. The woman who lost substantial weight is allowed to love what happened to her health and dislike what happened to her lower face.
Women do not need a moral defense for wanting to look fantastic.
Wanting smoother texture is not self-hatred. Wanting luminosity is not a failure to accept mortality. Wanting the face in the mirror to reflect the vitality you feel inside is not frivolous.
The problem was never wanting transformation.
The mistake was believing transformation requires treating skin like an adversary.
Skincare can be thoughtful without being timid. It can be conservative without being passive. It can be highly technical without being punishing, and extraordinarily ambitious without pretending the skin exists independently from the body living underneath it.
That is the referendum.
Stop interpreting every visible change as evidence that your skin is becoming an ever-growing collection of problems. Ask what changed. Ask what the skin may be responding to. Ask whether the products you accumulated for a different version of your skin still make sense for the conditions that exist today.
Keep what works. Change what doesn't. Support what needs support. Correct what you want corrected.
And when the conditions change again, change the strategy.
The woman postpartum did not fail to bounce back. The woman in menopause did not become a defective version of her younger self. The woman using a GLP-1 did not improve her health only to earn a new cosmetic diagnosis.
Their bodies changed, and their skin responded.
That response is information.
Read it. Then decide what to do.
Be conservative with disruption. Be ambitious about results.